Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Hido Technologies
AddedFeb 16, 2024
UpdatedJun 18, 2026
Hido Technologies

Hido Technologies

Seed

HiDO: An AI-powered platform streamlining home care and medication adherence, reducing hospital visits and enhancing patient independence.

HQ
El Dorado Hills, CA, US
Founded
2018
Overview
Compare
Fundraising
Employees
Website

Hido Technologies is dedicated to enhancing home care through its AI-powered medication adherence platform, HiDO. The platform aims to reduce hospitalizations and emergency room visits by up to 78% among chronic care patients, promoting health equity and independence at home. HiDO offers services such as AI behavioral monitoring, real-time population health management, and direct-to-patient trials, targeting the over 150 million Americans living with chronic conditions.

Hido Technologies has made significant strides in improving patient outcomes and reducing healthcare costs. By leveraging advanced AI to eliminate medication errors and facilitate behavioral modification, the company has positioned itself as a leader in home health care innovation. The platform's ability to recruit and retain diverse patient populations for clinical trials further underscores its impact on the healthcare industry.

Hido Technologies - Similar Companies

HealthID logo

HealthID

Hifinite logo

Hifinite

hifinite.com

H3C logo

H3C

h3ci.com

Redi.Health logo

Redi.Health

redi.health

AdhereTech logo

AdhereTech

adheretech.com

Medically Home logo

Medically Home

EveryDose logo

EveryDose

everydose.ai

Dina logo

Dina

dinacare.com

eternalHealth logo

eternalHealth

eternalhealth.com

Aida Healthcare logo

Aida Healthcare

aidahealthcare.com

iHealthHome logo

iHealthHome

Hoy Health logo

Hoy Health

hoyhealth.com

Videra Health logo

Videra Health

viderahealth.com

Tomorrow Health logo

Tomorrow Health

tomorrowhealth.com

AutoMedTech logo

AutoMedTech

Hido Technologies - Quick Facts

Who are Hido Technologies' competitors?

Companies similar to Hido Technologies include HealthID, Hifinite, H3C and Redi.Health.

When was Hido Technologies founded?

Hido Technologies was founded in 2018.

Where is Hido Technologies' headquarters located?

Hido Technologies' headquarters is located in El Dorado Hills, CA, US.

When was Hido Technologies' last funding round?

Hido Technologies' most recent funding round was for $500k (USD) in January 2022.

How much has Hido Technologies raised to-date?

As of Jan 1, 2022, Hido Technologies has raised a total of $1.4M (USD).

How many employees does Hido Technologies have?

Hido Technologies has 6 employees as of Feb 4, 2024.

Hido Technologies - Classification

Ownership
  • Venture Capital
Technology
  • AI
  • Machine Learning
Geographic Exposure
  • United States
Model
  • Platform
Revenue
  • Recurring
  • SaaS
Customer
  • Enterprise
Main Product
  • Home Healthcare
Tags
  • AI Operations
  • Healthcare
  • Healthtech
NAICS
  • 513200Software Publishers
  • 510000Information
  • 513000Publishing Industries
  • 513210Software Publishers
SIC
  • 7300Business Services
  • 7370Computer Programming, Data Processing, And Other Computer Related
  • 7372Prepackaged Software
Show 4 more industry codes
NAICS
  • 620000Health Care and Social Assistance
SIC
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified